231 related articles for article (PubMed ID: 35614383)
1. Characterization of erenumab and rimegepant on calcitonin gene-related peptide induced responses in Xenopus Laevis oocytes expressing the calcitonin gene-related peptide receptor and the amylin-1 receptor.
Hage La Cour S; Juhler K; Kogelman LJA; Olesen J; Klærke DA; Kristensen DM; Jansen-Olesen I
J Headache Pain; 2022 May; 23(1):59. PubMed ID: 35614383
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterisation of erenumab, Aimovig, at two calcitonin gene-related peptide responsive receptors.
Garelja ML; Alexander TI; Bennie A; Nimick M; Petersen J; Walker CS; Hay DL
Br J Pharmacol; 2024 Jan; 181(1):142-161. PubMed ID: 37580864
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.
Lee SM; Hay DL; Pioszak AA
J Biol Chem; 2016 Apr; 291(16):8686-700. PubMed ID: 26895962
[TBL] [Abstract][Full Text] [Related]
4. Migraine therapeutics differentially modulate the CGRP pathway.
Bhakta M; Vuong T; Taura T; Wilson DS; Stratton JR; Mackenzie KD
Cephalalgia; 2021 Apr; 41(5):499-514. PubMed ID: 33626922
[TBL] [Abstract][Full Text] [Related]
5. Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25.
Hay DL; Garelja ML; Poyner DR; Walker CS
Br J Pharmacol; 2018 Jan; 175(1):3-17. PubMed ID: 29059473
[TBL] [Abstract][Full Text] [Related]
6. Expression of the CGRP Family of Neuropeptides and their Receptors in the Trigeminal Ganglion.
Edvinsson L; Grell AS; Warfvinge K
J Mol Neurosci; 2020 Jun; 70(6):930-944. PubMed ID: 32086679
[TBL] [Abstract][Full Text] [Related]
7. Production of cAMP by adrenomedullin in human oligodendroglial cell line KG1C: comparison with calcitonin gene-related peptide and amylin.
Uezono Y; Nakamura E; Ueda Y; Shibuya I; Ueta Y; Yokoo H; Yanagita T; Toyohira Y; Kobayashi H; Yanagihara N; Wada A
Brain Res Mol Brain Res; 2001 Dec; 97(1):59-69. PubMed ID: 11744163
[TBL] [Abstract][Full Text] [Related]
8. Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy.
Mullin K; Kudrow D; Croop R; Lovegren M; Conway CM; Coric V; Lipton RB
Neurology; 2020 May; 94(20):e2121-e2125. PubMed ID: 31932515
[TBL] [Abstract][Full Text] [Related]
9. CGRP receptor antagonists for migraine. Are they also AMY
Garelja ML; Walker CS; Hay DL
Br J Pharmacol; 2022 Feb; 179(3):454-459. PubMed ID: 34076887
[TBL] [Abstract][Full Text] [Related]
10. CGRP, Amylin, Immunology, and Headache Medicine.
Taylor FR
Headache; 2019 Jan; 59(1):131-150. PubMed ID: 30390312
[TBL] [Abstract][Full Text] [Related]
11. CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist.
Hasbak P; Sams A; Schifter S; Longmore J; Edvinsson L
Br J Pharmacol; 2001 Aug; 133(8):1405-13. PubMed ID: 11498528
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of CGRP Signaling by Rimegepant at Two Receptors.
Pan KS; Siow A; Hay DL; Walker CS
Front Pharmacol; 2020; 11():1240. PubMed ID: 32973499
[TBL] [Abstract][Full Text] [Related]
13. Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine.
Berman G; Croop R; Kudrow D; Halverson P; Lovegren M; Thiry AC; Conway CM; Coric V; Lipton RB
Headache; 2020 Sep; 60(8):1734-1742. PubMed ID: 32799325
[TBL] [Abstract][Full Text] [Related]
14. CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?
Walker CS; Hay DL
Br J Pharmacol; 2013 Dec; 170(7):1293-307. PubMed ID: 23425327
[TBL] [Abstract][Full Text] [Related]
15. Calcitonin receptor, calcitonin gene-related peptide and amylin distribution in C1/2 dorsal root ganglia.
Rees TA; Tasma Z; Garelja ML; O'Carroll SJ; Walker CS; Hay DL
J Headache Pain; 2024 Mar; 25(1):36. PubMed ID: 38481170
[TBL] [Abstract][Full Text] [Related]
16. Cryo-EM Structure of the Human Amylin 1 Receptor in Complex with CGRP and Gs Protein.
Cao J; Belousoff MJ; Danev R; Christopoulos A; Wootten D; Sexton PM
Biochemistry; 2024 May; 63(9):1089-1096. PubMed ID: 38603770
[TBL] [Abstract][Full Text] [Related]
17. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
Tepper SJ
Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of erenumab in human isolated coronary and meningeal arteries: Additional effect of gepants on top of a maximum effect of erenumab.
de Vries T; Rubio-Beltrán E; van den Bogaerdt A; Dammers R; Danser AHJ; Snellman J; Bussiere J; MaassenVanDenBrink A
Br J Pharmacol; 2024 Jun; 181(12):1720-1733. PubMed ID: 38320397
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes.
Bailey RJ; Walker CS; Ferner AH; Loomes KM; Prijic G; Halim A; Whiting L; Phillips AR; Hay DL
Br J Pharmacol; 2012 May; 166(1):151-67. PubMed ID: 22014233
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin receptor antibody validation and expression in the rodent brain.
Hendrikse ER; Rees TA; Tasma Z; Le Foll C; Lutz TA; Siow A; Wookey PJ; Walker CS; Hay DL
Cephalalgia; 2022 Aug; 42(9):815-826. PubMed ID: 35410497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
